
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $81.2M | -- | -- | $0.08 | -- |
07/30/2025 | Q2 | $80.3M | -- | -- | $0.08 | -- |
04/30/2025 | Q1 | $75.9M | $79.1M | $0.07 | $0.07 | -- |
01/30/2025 | Q4 | $71.5M | $74.8M | $0.08 | $0.06 | $0.02 |
10/30/2024 | Q3 | $72.8M | $75.1M | $0.06 | $0.06 | -- |
07/30/2024 | Q2 | $70.3M | $75.5M | $0.07 | $0.06 | $0.01 |
04/30/2024 | Q1 | $68.6M | $77.1M | $0.07 | $0.06 | $0.02 |
01/30/2024 | Q4 | $68.3M | $75.4M | $0.07 | $0.06 | $0.01 |
10/26/2023 | Q3 | -- | -- | $0.07 | $0.05 | $0.02 |
07/27/2023 | Q2 | -- | -- | $0.06 | $0.04 | $0.03 |
04/27/2023 | Q1 | -- | -- | $0.06 | $0.07 | -$0.01 |
01/26/2023 | Q4 | -- | -- | $0.08 | $0.08 | -- |
09/30/2022 | Q3 | -- | -- | $0.09 | $0.08 | $0.01 |
07/28/2022 | Q2 | -- | -- | $0.06 | $0.06 | $0.00 |
04/28/2022 | Q1 | -- | -- | $0.06 | $0.06 | $0.00 |
01/27/2022 | Q4 | -- | -- | $0.06 | $0.06 | $0.00 |
11/24/2021 | Q3 | -- | -- | $0.06 | $0.06 | $0.00 |
07/29/2021 | Q2 | -- | -- | $0.06 | $0.06 | -- |
05/06/2021 | Q1 | -- | -- | $0.08 | $0.07 | $0.01 |
02/09/2021 | Q4 | -- | -- | $0.09 | $0.07 | $0.02 |
11/24/2020 | Q3 | -- | -- | $0.05 | $0.06 | -$0.01 |
08/07/2020 | Q2 | -- | -- | $0.10 | $0.05 | $0.06 |
05/15/2020 | Q1 | -- | -- | $0.06 | $0.05 | $0.02 |
01/30/2020 | Q4 | -- | -- | $0.09 | $0.06 | $0.03 |
10/30/2019 | Q3 | -- | -- | $0.08 | $0.06 | $0.02 |
08/07/2019 | Q2 | -- | -- | $0.06 | $0.07 | -$0.01 |
05/08/2019 | Q1 | -- | -- | $0.07 | $0.07 | -$0.00 |
01/30/2019 | Q4 | -- | -- | $0.07 | $0.08 | -$0.01 |
10/29/2018 | Q3 | -- | -- | $0.08 | $0.08 | -$0.00 |
07/30/2018 | Q2 | -- | -- | $0.07 | $0.09 | -$0.02 |
04/30/2018 | Q1 | -- | -- | $0.08 | $0.09 | -$0.01 |
01/30/2018 | Q4 | -- | -- | $0.09 | $0.08 | $0.01 |
10/30/2017 | Q3 | -- | -- | $0.08 | $0.08 | -- |
07/27/2017 | Q2 | -- | -- | $0.08 | $0.07 | $0.01 |
04/28/2017 | Q1 | -- | -- | $0.08 | $0.07 | $0.01 |
02/08/2017 | Q4 | -- | -- | $0.07 | $0.07 | -- |
10/27/2016 | Q3 | -- | -- | $0.08 | $0.07 | $0.01 |
07/29/2016 | Q2 | -- | -- | $0.07 | $0.07 | -- |
05/05/2016 | Q1 | -- | -- | $0.07 | $0.06 | $0.01 |
02/04/2016 | Q4 | -- | -- | $0.06 | $0.06 | -- |
11/04/2015 | Q3 | -- | -- | $0.08 | $0.06 | $0.02 |
TFS Financial reported $79.1M worth of top line sales in its most recent quarter.
TFS Financial announced earnings per share of $0.07 which represents a miss of analyst forecast a $0.07 per share.
TFS Financial reported -- that represents -- per share over the last quarter.
TFS Financial's earnings are forecast to grow from $0.28 per share to $0.27 per share next year representing an increase of 10.71%.
TFS Financial's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.